Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: MMP Ownership according to TPL?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Ownership

  • PTSC - 50%
  • Chuck Moore - 27.5%
  • TPL Group - 22.5%

Control and right to license

  • TPL Group - 100%

How does that mesh with the revised agreements that were filed a few weeks back?

7 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply